Trial Profile
Effect of a Peg-interferon alfa 2A pulse on HBV-specific T cell responses in chronic hepatitis HBeAg negative patients under long-term nucleos(t)ide treatment
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 Mar 2015
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Entecavir; Tenofovir disoproxil fumarate
- Indications Hepatitis B
- Focus Therapeutic Use
- 13 Mar 2015 New trial record